GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats (Q45242151)

11 December 2017

GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats (English)

1 reference

11 December 2017

1 reference

3

Min Liu

1 reference

11 December 2017

Xiaofa Qin

1

1 reference

11 December 2017

Hui Shen

2

1 reference

11 December 2017

Qing Yang

4

1 reference

11 December 2017

Shuqin Zheng

5

1 reference

11 December 2017

Mary Sabo

6

1 reference

11 December 2017

David A D'Alessio

7

1 reference

11 December 2017

Patrick Tso

8

1 reference

11 December 2017

27 January 2005

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

11 December 2017

1 reference

11 December 2017

288

1 reference

11 December 2017

G943-9

1 reference

11 December 2017

5

1 reference

Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid

11 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

21 January 2018

Glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Minireview: the glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Ileal carbohydrates inhibit cholinergically stimulated exocrine pancreatic secretion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Glucagon-like peptide-1 analogue LY315902: effect on intestinal motility and release of insulin and somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

The role of apolipoprotein A-IV in the regulation of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7-36 amide) without affect on mRNA level in isolated rat islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Ileal release of glucagon-like peptide-1 (GLP-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

Inhibition of human gastric lipase secretion by glucagon-like peptide-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00303.2004

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00303.2004

1 reference

11 December 2017

1 reference